🔴 Cabaletta Bio is trading 5.1% down in pre-market as Nasdaq Composite falls 0.53%

Cabaletta Bio is trading 5.1% down at $2.95 as broader market sentiment weakens.

• Shares closed at $3.11 on August 31, 2026.
• No fresh company-specific announcement, earnings release, financing, regulatory action, or analyst catalyst was identified for September 1, 2026.
• The Nasdaq Composite is down 0.53%, while geopolitical tensions, higher oil prices, and elevated Treasury yields weigh on risk appetite.